ENCARNACIÓN
GONZÁLEZ RODRÍGUEZ
Researcher in the period 1994-2022


Hospital Universitario Reina Sofia
Córdoba, EspañaPublications in collaboration with researchers from Hospital Universitario Reina Sofia (10)
2024
-
Sequential RAS mutations evaluation in cell-free DNA of patients with tissue RAS wild-type metastatic colorectal cancer: the PERSEIDA (Cohort 2) study
Clinical and Translational Oncology, Vol. 26, Núm. 10, pp. 2640-2651
2021
-
Patient profiles as an aim to optimize selection in the second line setting: the role of aflibercept
Clinical and Translational Oncology, Vol. 23, Núm. 8, pp. 1520-1528
2019
-
SEOM clinical guidelines for diagnosis and treatment of metastatic colorectal cancer (2018)
Clinical and Translational Oncology, Vol. 21, Núm. 1, pp. 46-54
-
SEOM clinical guidelines for the diagnosis and treatment of gastroenteropancreatic and bronchial neuroendocrine neoplasms (NENs) (2018)
Clinical and Translational Oncology, Vol. 21, Núm. 1, pp. 55-63
2016
-
SEOM Clinical Guideline of localized rectal cancer (2016)
Clinical and Translational Oncology, Vol. 18, Núm. 12, pp. 1163-1171
2014
-
Second primary malignancies in patients with neuroendocrine tumors
Clinical and Translational Oncology, Vol. 16, Núm. 10, pp. 921-926
2012
-
Phase II study of preoperative radiotherapy and concomitant weekly intravenous oxaliplatin combined with oral capecitabine for stages II-III rectal cancer
Clinical and Translational Oncology, Vol. 14, Núm. 8, pp. 592-598
2010
-
SEOM clinical guidelines for the treatment of advanced colorectal cancer
Clinical and Translational Oncology, Vol. 12, Núm. 11, pp. 729-734
2009
-
Elderly patients with advanced colorectal cancer derive similar benefit without excessive toxicity after first-line chemotherapy with oxaliplatin-based combinations: Comparative outcomes from the 03-TTD-01 phase III study
Critical Reviews in Oncology/Hematology, Vol. 70, Núm. 2, pp. 134-144
2008
-
A Phase II study of weekly vinorelbine and trastuzumab in patients with HER2-positive metastatic breast cancer
Clinical Breast Cancer, Vol. 8, Núm. 3, pp. 264-268